$15.76
5.14%
Nasdaq, Sep 05, 10:00 pm CET
ISIN
US05337M1045
Symbol
AVDL

Avadel Pharmaceuticals PLC Sponsored ADR Stock price

$15.76
+4.61 41.35% 1M
+7.89 100.25% 6M
+5.25 49.95% YTD
+1.14 7.76% 1Y
+9.14 138.07% 3Y
+9.35 145.87% 5Y
-6.50 29.20% 10Y
-0.51 3.13% 20Y
Nasdaq, Closing price Fri, Sep 05 2025
+0.77 5.14%
ISIN
US05337M1045
Symbol
AVDL
Industry

Key metrics

Basic
Market capitalization
$1.5b
Enterprise Value
$1.4b
Net debt
positive
Cash
$81.6m
Shares outstanding
96.8m
Valuation (TTM | estimate)
P/E
negative | 65.2
P/S
6.9 | 5.5
EV/Sales
6.6 | 5.2
EV/FCF
274.9
P/B
16.9
Financial Health
Equity Ratio
45.0%
Return on Equity
-66.1%
ROCE
1.7%
ROIC
1.2%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$221.1m | $277.0m
EBITDA
$5.9m | $37.0m
EBIT
$2.3m | $28.9m
Net Income
$-2.9m | $23.4m
Free Cash Flow
$5.3m
Growth (TTM | estimate)
Revenue
132.4% | 63.8%
EBITDA
106.0% | 193.2%
EBIT
102.3% | 168.3%
Net Income
97.3% | 147.9%
Free Cash Flow
104.6%
Margin (TTM | estimate)
Gross
89.6%
EBITDA
2.7% | 13.4%
EBIT
1.0%
Net
-1.3% | 8.5%
Free Cash Flow
2.4%
More
EPS
$0.0
FCF per Share
$0.1
Short interest
12.2%
Employees
188
Rev per Employee
$900.0k
Show more

Is Avadel Pharmaceuticals PLC Sponsored ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,003 stocks worldwide.

Avadel Pharmaceuticals PLC Sponsored ADR Stock Analysis

Unlock Scores for Free

Analyst Opinions

14 Analysts have issued a Avadel Pharmaceuticals PLC Sponsored ADR forecast:

13x Buy
93%
1x Hold
7%

Analyst Opinions

14 Analysts have issued a Avadel Pharmaceuticals PLC Sponsored ADR forecast:

Buy
93%
Hold
7%

Financial data from Avadel Pharmaceuticals PLC Sponsored ADR

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
221 221
132% 132%
100%
- Direct Costs 23 23
347% 347%
10%
198 198
120% 120%
90%
- Selling and Administrative Expenses 179 179
2% 2%
81%
- Research and Development Expense 17 17
35% 35%
8%
5.86 5.86
106% 106%
3%
- Depreciation and Amortization 3.60 3.60
131% 131%
2%
EBIT (Operating Income) EBIT 2.26 2.26
102% 102%
1%
Net Profit -2.92 -2.92
97% 97%
-1%

In millions USD.

Don't miss a Thing! We will send you all news about Avadel Pharmaceuticals PLC Sponsored ADR directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Avadel Pharmaceuticals PLC Sponsored ADR Stock News

Neutral
GlobeNewsWire
3 days ago
– 17 abstracts accepted, including one oral presentation – – Data from the REFRESH real-world study highlight efficacy of once-nightly sodium oxybate when switching from twice-nightly oxybates – – REFRESH study also highlights efficacy in those who were new to oxybate or returning to oxybate after discontinuing twice-nightly oxybate – DUBLIN, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceut...
Neutral
GlobeNewsWire
4 days ago
– Expands Avadel's pipeline with salt-free, artificial sweetener-free, once-at-bedtime oxybate for treatment of narcolepsy and idiopathic hypersomnia –
Neutral
GlobeNewsWire
10 days ago
DUBLIN, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of management will participate in the following upcoming investor conferences: 2025 Wells Fargo Healthcare Conference: Fireside chat on Friday, September 5 at 11:00 a.m. ET. Morgan Stanley 23rd Annual ...
More Avadel Pharmaceuticals PLC Sponsored ADR News

Company Profile

Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. It offers Bloxiverz, Vazculep, and Akovaz. The company was founded on December 1, 2015 and is headquartered in Dublin, Ireland.

Head office Ireland
CEO Gregory Divis
Employees 188
Founded 2015
Website www.avadel.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today